
|Articles|December 1, 2012
- Pharmaceutical Executive-12-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - December 2012
The Puzzle Master
Advertisement
Articles in this issue
over 13 years ago
Obamacare, Innovation and Pricingover 13 years ago
Germany's Price Reform Revolutionover 13 years ago
Transforming Drug Development: A Lilly–Covance Case Studyover 13 years ago
The Puzzle Master: EMA's Guido Rasiover 13 years ago
Top Medical Innovations for 2013Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
2
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
3
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5




